Michael E. Kamarck
- Immunology and Allergy top 2%
- Immunology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 10
- Radiopharmaceutical Chemistry and Applications 2
- Epidemiology top 10%
-
- Virus-based gene therapy research 7
-
- RNA Interference and Gene Delivery 5
- CRISPR and Genetic Engineering 4
- Glycosylation and Glycoproteins Research 2
-
- CAR-T cell therapy research 4
-
- Alzheimer's disease research and treatments 2
Michael E. Kamarck
29 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Immunology and Allergy 252
- Immunology 486
- Radiology, Nuclear Medicine and Imaging 409
- Cardiology and Cardiovascular Medicine 276
- Epidemiology 388
Countries citing papers authored by Michael E. Kamarck
This map shows the geographic impact of Michael E. Kamarck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Kamarck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Kamarck more than expected).
Fields of papers citing papers by Michael E. Kamarck
This network shows the impact of papers produced by Michael E. Kamarck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Kamarck. The network helps show where Michael E. Kamarck may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael E. Kamarck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 20 | |
| 2 | 2006 | 31 | |
| 3 | 1994 | 58 | |
| 4 | 1991 | 14 | |
| 5 | 1990 | 36 | |
| 6 | 1987 | 32 | |
| 7 | cDNA cloning and mapping of the human creatine kinase M gene to 19q13. | 1987 | 53 |
| 8 | 1987 | 2 | |
| 9 | 1987 | 6 | |
| 10 | 1984 | 27 | |
| 11 | 1984 | 19 | |
| 12 | 1984 | 1 | |
| 13 | 1983 | 4 | |
| 14 | 1983 | 4 | |
| 15 | 1982 | 26 | |
| 16 | 1982 | 36 | |
| 17 | 1982 | 1 | |
| 18 | 1981 | 22 | |
| 19 | 1977 | 28 | |
| 20 | The isolation and characterization of polycyclic hydrocarbon-binding proteins from mouse liver and skin cytosols. | 1975 | 27 |
About Michael E. Kamarck
Michael E. Kamarck is a scholar working on Radiology, Nuclear Medicine and Imaging, Biotechnology, Immunology, Genetics and Molecular Biology, having authored 29 papers that have together received 1.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Virus-based gene therapy research (7 papers), RNA Interference and Gene Delivery (5 papers), CAR-T cell therapy research (4 papers), CRISPR and Genetic Engineering (4 papers), Glycosylation and Glycoproteins Research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Alzheimer's disease research and treatments (2 papers). The work is most often cited by research in Immunology and Allergy (252 citations), Immunology (486 citations), Radiology, Nuclear Medicine and Imaging (409 citations), Cardiology and Cardiovascular Medicine (276 citations) and Epidemiology (388 citations). Michael E. Kamarck has collaborated with scholars based in United States and Canada. Frequent co-authors include Gary L. Davis, Alan McClelland, Susan Yost, Jeffrey M. Greve, Christopher W. Marlor, Carla Forte, John Hart, J A Barbosa, James J. Elting and Frank H. Ruddle. Their work appears in journals such as The Journal of Immunology, Experimental Cell Research, Journal of Immunological Methods, Proceedings of the National Academy of Sciences and Methods in enzymology on CD-ROM/Methods in enzymology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.